Researcher
Conny Gysemans
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
11 - 17 of 17
- Optimizing antigen-specific immunotherapy in type 1 diabetes.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Boosting beta-cell function for treatment of type 1 diabetesFrom1 Jun 2012 → 22 Dec 2016Funding: BOF - Doctoral projects
- Harnessing the vitamin D system for the prevention and treatment of type 1 diabetes.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
- NOVEL IMMUNOTHERAPIES IN TYPE 1 DIABETES: EXPLORING ANTIGEN-SPECIFIC AND NON-SPECIFIC APPROACHESFrom1 Oct 2009 → 16 Sep 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
- Prevention or delay of weta-cell destruction in animal models of type-1 diabetes via use of histone deacetylase inhibitors.From1 Jan 2009 → 31 Dec 2011Funding: FWO research grant KAN
- ActoBiotics for antigen-specific intervention in type 1 diabetes: mono- and combination therapy.From1 Sep 2008 → 17 Jul 2014Funding: Baekeland
- Protecting the beta cell in type 1 diabetes mellitus through better understanding of the intracellular signaling cascades: interventions in pre-clinical models.From1 Jan 2008 → 31 Dec 2011Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 138
- HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes(2024)
Authors: Conny Gysemans
- Neutrophils: a driving force in type 1 diabetes?(2023)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
- Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
- MULTI-OMICS TECHNOLOGIES TO IDENTIFY BIOMARKERS FOR THERAPY PREDICTION AND RESPONSE IN TYPE 1 DIABETES(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
- A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes(2023)
Authors: Gabriele Sassi, Amber Wouters, Pierre Lemaitre, Samal Bissenova, Conny Gysemans
- High-Throughput Analysis of Neutrophil Extracellular Trap Le of People with Type 1 Diabetes(2023)
Authors: Samal Bissenova, Markus Bösch, Hannelie Korf, Kristina Casteels, An Teunkens, Chantal Mathieu, Conny Gysemans
- NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins(2023)
Authors: Samal Bissenova, Rita Derua, Chantal Mathieu, Conny Gysemans, Lut Overbergh
- Neutrophils in autoimmunity: when the hero becomes the villain(2022)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
Pages: 128 - 140 - Preventing type 1 diabetes in late-stage pre-diabetic NOD mice with insulin: A central role for alum as adjuvant(2022)
Authors: Pieter-Jan Martens, Ylke Bruggeman, Chantal Mathieu, Conny Gysemans
- High Serum Vitamin D Concentrations, Induced via Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice(2022)
Authors: Pieter-Jan Martens, Gabriele Sassi, Lieve Verlinden, Mieke Verstuyf, Jeroen Raes, Chantal Mathieu, Conny Gysemans
Patents
1 - 4 of 4
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)